Medical University of Vienna Reaccreditation 1 ID:700. Initial accreditation ID:777. Cliniques Universitaires St Luc Reaccreditation 2 ID:768
|
|
|
- Lee Lamb
- 6 years ago
- Views:
Transcription
1 1. Austria Vienna BMT Unit, First Medical Department 2. Belgium Centrum voor Oncologie, Autoloog stamceltransplantatie programma Medical University of Vienna AZ Turnnhout vzw, Campus Sint- Elisabeth ID: Belgium Brussels Programme de transplantation de cellules souches hématopoïétiques adulte et pédiatrique Cliniques Universitaires St Luc Cliniques Universitaires St Luc ID: Belgium Hasselt Dienst Hematologie Jessa Ziekenhuis, campus Virga Jesse ID: Croatia Zagreb Department of Transfusion Medicine 6. Czech Republic Prague University Hospital Centre Zagreb Institute of Haematology and Blood Transfusion ID:777 ID: Finland Helsinki Helsinki University Central Hospital 8. France Boulogne-surmer Service d Hematologie CH Dr Duchenne - Hôpital Boulogne Sur Mer ID:788 ID:742 ID:
2 9. France Grenoble Grenoble allogreffe CHU Grenoble 10. France Lyon Hospices Civils de Lyon (HCL) - Service d hématologie clinique ID:613 Centre Hospitalier Lyon Sud (CHLS) 11. France Lyon Institut d Hématologie et d Oncologie Pédiatrique, IHOPe - Lyon ID: France Lyon Service Emile POMMATAU Centre Léon Bérard 13. France Marseille Transplantation et Thérapie Cellulaire Institut Paoli-Calmettes Marseille 14. France Montpellier Département d hématologie clinique - Hôpital St Eloi 15. France Nantes Programme de Greffe de Moelle du CHU de Nantes ID:770 ID:489 Institut Paoli-Calmettes ID:794 CHU de Montpellier ID:714 CHU de Nantes 16. France Nice Autogreffe CAL Centre Antoine Lacassagne ID:783 ID:
3 17. France Paris Hopital de la Pietié-Salpetrière 18. France Paris Programme Adulte de Greffe de CSH Necker Enfants-Malades 19. France Paris Service d Hématologie clinique Hôpitaux Universitaires Pitié Salpêtrière - Charles - Foix 20. France Rouen Programme de greffe de Cellules Souches Hématopoïétiques chez l'adulte à Rouen, Haematology Department Centre Henri Becquerel ROUEN / Etablissement Français du Sang BOIS GUILLAUME 21. France Villejuif Programme de transplantation des Cellules Souches Hématopoïétiques. Departement d Hématologie. ID:632 Hôpital Necker Enfants-Malades ID:766 ID:588 Centre Henri Becquerel Institut Gustave Roussy ID: France Villejuif Greffe autologue pédiatrique Institut Gustave Roussy 23. Germany Essen Evangelisches Krankenhaus Essen-Werden Klinik für Hämatologie/ Onkologie/Stammzelltransplantation ID:737 ID:738 ID:
4 24. Germany Kiel University Hospital Schleswig- Holstein 25. Germany Kiel II. Medical Department, Division of Stem Cell Transplantation and Immunotherapy 26. Germany Regensburg Stammzelltransplantationszentrum Regensburg Institute of Transfusion Medicine University Hospital Schleswig- Holstein, Campus Kiel, ID:760 ID:750 Universitätsklinikum Regensburg 27. Germany Würzburg University Children s Hospital University Medical Center Würzburg 28. Germany Würzburg Adult Stem Cell Transplantation Program 29. Greece Athens BMT Unit, Oncology Center Marianna V. Vardinogianni Elpida, Aghia Sophia Children s Hospital, Athens 30. Greece Thessaloniki G. Papanicolaou Hospital Department of Haematology - Haematopoietic Cell Transplantation Centre ID:720 ID:736 University Medical Center Würzburg Aghia Sophia Children s Hospital G. Papanicolaou Hospital Department of Haematology - Haematopoietic Cell Transplantation Centre 31. Ireland Dublin Our Lady's Children's Hospital Crumlin ID:735 ID:774 ID:775 ID:
5 32. Israel Jerusalem Department of Bone Marrow Transplantation Hadassah University Medical Center 33. Italy Ancona Clinica di Ematologia Azienda Ospedaliera Universitaria Ospadali Riuniti Ancona ID: Italy Napoli SSD TMO Aorn Santobono Pausilipon 35. Italy Reggio Emilia Centro Trapianti di cellule staminali emopoietiche di Reggio Emilia 36. Italy Rome LMCC, UOC MEDICINA TRASFUSIONALE Arcispedale Santa Maria Nuova IRCCS Reggio Emilia Azienda Ospedaliera S. Giovanni Addolorata 37. Italy Rome Fondazione Policlinico Universitario A. Gemelli - Università Cattolica S. Cuore Roma 38. Italy Torino Programma di trapianto di cellule staminali emopoietiche, Divisione Ematologia Univ. 39. Italy Torino Centro Trapianti Cellule Staminali e Terapia Cellulare (CTCS), Metropolitan Transplant Programme AOU Città della Salute e della Scienza di Torino AOU Città della Salute e della Scienza di Torino, Ospedale Infantile Regina Margherita ID:646 ID:653 ID:764 ID:755 ID:791 ID:767 ID:
6 40. Italy Verona Centro Trapianto Midollo Osseo (CTMO) UOC di Ematologia & UOC di Oncoematologia Pediatrica 41. Netherlan 42. Netherlan 43. Netherlan 44. Netherlan 45. Netherlan 46. Netherlan Azienda Ospedaliera Universitaria Integrata ID:543 Amsterdam Laboratory for Cell Therapy Sanquin Research Reaccreditation 3 ID:806 Amsterdam Department of Haematology VU Medical Centre Reaccreditation 3 Amsterdam Maastricht Stem Cell Transplantation Programme Stem Cell Transplantation Programme, Department Haematology The Netherlan Cancer Institute- Antoni van Leeuwenhoek Hospital (NKI-AVL) Antoni van Leeuwenhoek Hospital ID:816 ID:741 Maastricht University Medical Center ID:746 The Hague Department of Hematology Haga Hospital Utrecht Department of Haematology - Clinical Facility, dept. of Hematology-RvE -Clinical Facility, dept. of WKZ -Stem Cell Collection (Sanquin) -Stem Cell Processing Laboratory ID:751 University Medical Center Utrecht ID:
7 47. South Africa PRETORIA ALBERT ALBERTS STEM CELL TRANSPLANT CENTRE ALBERT ALBERTS STEM CELL TRANSPLANT CENTRE CIC Spain Barcelona Hospital Duran i Reynals Instituto Catalan de Oncologia (ICO) 49. Spain Barcelona Programa de Trasplante Pediátrico de Progenitores Hematopoyéticos 50. Spain Murcia Servicio de Hematología y Oncología Médica 51. Sweden Lund Department of Hematology and Oncology (Adult Unit) 52. Switzerlan d 53. Switzerlan d 54. Switzerlan d Berne SZT Programm DOLS & DFKE Universitätsspital Inselspital Bern, Switzerland ID:778 ID:769 Hospital Universitario Vall d Hebron Hospital Universitario Morales Meseguer Skane University Hospital University Hospital Berne Paediatric Hematology / Oncology ID:732 Reaccreditation 3 ID:779 ID:698 Reaccreditation 3 ID:776 Geneva UHSCT Hôpitaux Universitaires de Genève Lausanne Centre Hospitalier Universaire Vaudois (CHUV) ID:793 ID:
8 55. Switzerlan d 56. United 57. United 58. United 59. United 60. United 61. United 62. United Zürich Birmingham Department of Stem Cell Transplantation University Children's Hospital Zürich BIRMINGHAM CHILDRENS HOSPITAL NHS FOUNDATION TRUST ID:703 ID:693 Birmingham Centre for Clinical Haematology Queen Elizabeth Hospital ID:729 Blackpool Blackpool Victoria Hospital Blackpool Victoria Hospital Bristol Cambridge Exeter Glasgow Bone Marrow Transplant Unit and Bristol Haematology Unit Addenbrookes Hospital Blood and Marrow Transplant Program High Dose Chemotherapy Programme Autologous Blood Stem Cell Transplantation Haemopoietic Stem Cell Processing Laboratory, Department of Haematology ID:712 Bristol Royal Hospital for Children Reaccreditation 3 ID:730 Addenbrookes Hospital Royal Devon and Exeter NHS Foundation Trust ID:761 ID:733 NHS Greater Glasgow & Clyde ID:
9 63. United 64. United 65. United 66. United 67. United 68. United 69. United 70. United Hull Liverpool London Queens Centre for Oncology & Haematology Stem Cell & Immunotherapies Laboratories Great Ormond Street Hospital for Children NHS Foundation Trust Hull and East Yorkshire Hospitals NHS Trust ID:719 NHS Blood and Transplant Liverpool ID:724 Great Ormond Street Hospital ID:772 London Cancer Services London Bridge Hospital London The Transplant Progr amme The Royal Marsden Hospital NHS Foundation Trust London Norwich Norfolk and Norwich Haematopoietic Stem Cell Transplant Service Imperial College Healthcare NHS Trust Norfolk and Norwich University Hospital NHS Foundation Trust Nottingham Apheresis Unit Nottingham University Hospitals NHS Trust ID:706 ID:787 ID:728 ID:786 Reaccreditation 3 ID:
10 71. United 72. United 73. United 74. United 75. United Nottingham Nottingham City Hospital Nottingham University Hospitals NHS Trust Reaccreditation 3 ID:756 Poole Cancer Centre Poole Hospital NHS Foundation Trust Southampton Stoke-on- Trent Cellular and Molecular Therapies (CMT) Department of Clinical Hematology, Ward 201 Warwick Warwick Hospital, Apheresis Unit South Warwickshire Hospitals Foundation Trust ID:695 NHS Blood and Transplant ID:765 University Hospital of North Midlan ID:747 ID:
Clinical-Adult-Auto: X cellules souches hématopoïétiques adulte et. Clinical-Adult-Allo: X pédiatrique Cliniques ID:768
has completed following initial 1. Belgium Brussels Programme de transplantation de Cliniques Universitaires St Luc cellules souches hématopoïétiques adulte et ID:768 pédiatrique Cliniques Universitaires
INCIDENCE OF ADENOVIRUS INFECTIONS IN PEDIATRIC AND ADULT ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS IN EUROPE
INCIDENCE OF ADENOVIRUS INFECTIONS IN PEDIATRIC AND ADULT ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS IN EUROPE Sebastian Voigt, 1 Cécile Pochon, 2 Kanchan Rao, 3 Antonio Pérez-Martínez, 4 Marco
ADENOVIRUS VIRAL BURDEN IS ASSOCIATED WITH MORTALITY IN PEDIATRIC ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: RESULTS FROM THE ADVANCE STUDY
ADENOVIRUS VIRAL BURDEN IS ASSOCIATED WITH MORTALITY IN PEDIATRIC ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: RESULTS FROM THE ADVANCE STUDY Marco Zecca, 1 Kanchan Rao, 2 Antonio Pérez-Martínez,
SIOPEL 6. International Childhood Liver Tumour Strategy Group - SIOPEL. Eudract Number:
SIOPEL 6 A multi-centre open label randomised phase III trial of the efficacy of Sodium Thiosulphate in reducing ototoxicity in patients receiving cisplatin chemotherapy for STANDARD RISK HEPATOBLASTOMA
Short Study Report for Health Authorities
the Active Title of the Study Randomised trial of single agent doxorubicin versus doxorubicin plus ifosfamide in the first line treatment of advanced or metastatic soft tissue sarcoma Investigators & Study
ASCONA 07/11/08 PAEDIATRIC ONCOLOGY. 2 nd ESO-SIOPE MASTERCLASS IN November 2008 Ascona, Switzerland
MASTERCLASS ASCONA 07/11/08 2 nd ESO-SIOPE MASTERCLASS IN PAEDIATRIC ONCOLOGY 7-13 November 2008 Ascona, Switzerland Chair: R. Riccardi, IT - M.C.G. Stevens, UK - A. Eggert, DE Educational Advisor: W.
European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment ExPO-r-Net
Consumers, Health and Food Executive Agency European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment 2013 12 07 ExPO-r-Net 1 Quality of the partnership Background The project
Table Of Content. Outputs... 8
Table Of Content The PRES European Network of Registries for Autoinflammatoy Diseases in childhood.... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Assistance publique Hôpitaux de Paris-Centre
University of Texas M.D. Anderson Cancer Center. #1 in Cancer. #6in Gynecology #23in Urology. Duke University Medical Center.
US The full list of our network (attached) includes around 400 Hospital across the United States. Our network includes the main Center of Excellence in the US. Please see below samples of hospitals included
EBMT Society EBMT. History Organisation Studies Activity Philosophy. EBMT Website. European Group for Blood and Marrow Transplantation
EBMT EBMT Organisation and Activities J Apperley 13th. ESH-EBMT Training Course Targu Mures May 24 26, 2010 History Organisation Studies Activity Philosophy EBMT Website www.ebmt.org EBMT Society European
Table Of Content. Outputs... 8
Table Of Content European registry and network for Intoxication type Metabolic Diseases... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants
Principal Treatment Centres What do the data say for childhood cancer?
Principal Treatment Centres What do the data say for childhood cancer? Charles Stiller National Registry of Childhood Tumours (NRCT) Childhood Cancer Research Group (CCRG) Children s Cancer and Leukaemia
OVARIAN. CANCER Optimal Therapy. Update ADVANCED. 12 th International Symposium. Valencia, 22 nd February
Organized by Valencia, 22 nd February 2019 12 th International Symposium ADVANCED OVARIAN CANCER Optimal Therapy. Update DIRECTORS Andrés Poveda Initia Oncology, Hospital Quirónsalud, Valencia, Spain Jan
Immunotherapy of childhood cancer
Immunotherapy of childhood cancer Co-Presidents of the meeting Franco Locatelli University of Pavia Department of Pediatric Hematology and Oncology Bambino Gesù Children s Hospital, Rome, Italy Lorenzo
Bendamustine + Rituximab (BR) Project
Bendamustine + Rituximab (BR) Project Efficacy and tolerability of Bendamustine and Rituximab in first line and second line treatment in CLL An observational study proposed by the ERIC-GIMEMA groups Rationale
National Haemoglobinopathy Registry. Annual Report 2017/18
National Haemoglobinopathy Registry Annual Report 2017/18 National Haemoglobinopathy Registry Annual Report (2017/18) Compiled by Mark Foster MDSAS 3 1 Introduction CHAPTER 1 The 2017/18 Annual Report
Periodic Report 1.1 Y1 / M6-M12
Periodic Report 1.1 Y1 / M6-M12 EURACAN EUROPEAN REFERENCE NETWORK ON RARE ADULT CANCERS Call: Health programme Specific Grant agreement: 769029 Coordinator: CLB Start date: 1 st March 2017 Duration: 12
0a)le of contents. E ecutive Summary. Goals. MyPeBS in short. Consortium. Participants. Contact us
Octo)er 8 0a)le of contents E ecutive Summary Conte t Goals MyPeBS in short 05 Consortium Participants Contact us Octo)er 8 Executive summary MyPeBS is an innovative international research project, funded
Table Of Content. Outputs... 7
Table Of Content Better control in paediatric and adolescent diabetes in the EU: working to create Centres of Reference... 2 Summary... 3 Coordinator, Leader contact and partners... 4 Hannover Medical
Trends in mortality from leukemia in subsequent age groups
(2000) 14, 1980 1985 2000 Macmillan Publishers Ltd All rights reserved 0887-6924/00 $15.00 www.nature.com/leu Trends in mortality from leukemia in subsequent age groups F Levi 1, F Lucchini 1, E Negri
Progress and Controversies in Gynecologic Oncology Conference
2013 This meeting is a prime Oncology activity. Progress and Controversies in Gynecologic Oncology Conference 15-16 February 2013 Haliç Congress Center Istanbul, Turkey www.primeoncology.org/gyncongress2013
ECTRIMS MULTIPLE SCLEROSIS CLINICAL TRAINING FELLOWS Awardees
ECTRIMS MULTIPLE SCLEROSIS CLINICAL TRAINING FELLOWS 2019 Awardees Simón Cárdenas Robledo, MD Centre d'esclerosi Multiple de Catalunya (Cemcat), Barcelona, Spain Dr. Mar Tintoré Paula Tagliani, MD Vall
Supplement to: Intensity of factor VIII treatment and inhibitor development in previously
Supplementary Material Supplement to: Intensity of factor VIII treatment and inhibitor development in previously untreated patients with severe hemophilia A: the RODIN study Table of contents List of investigators
Thyrotrophin Releasing Hormone
Thyrotrophin Releasing Hormone Frontiers of Hormone Research Vol. 1 M. Maroís, París S. Karger Basel München Paris London New York Sydney Workshop Conference on Thyrotrophin Releasing Hormone, Basel, April
Cardiomyopathy and Myocarditis Registry. Newsletter N 16 October Dear Investigators,
Cardiomyopathy and Myocarditis Registry Newsletter N 16 October 2016 Page 1 Some words from the Chairman Dear Investigators, Page 2 to 4. - Study plan - Registry status - Some key variables Page 4 to 6
RESEARCH PROGRESS Together
Together PROGRESS Research & Progress Together Lymphoma, the sixth cancer worldwide in terms of incidence, is a complex disease. ELI, The European Lymphoma Institute, regroups top European specialists
National Haemoglobinopathy Registry. Annual Report 2015/16. mdsas
National Haemoglobinopathy Registry Annual Report 2015/16 mdsas National Haemoglobinopathy Registry Annual Report (2015/16) 3 1 Introduction CHAPTER 1 This 2015/16 data update follows the same format as
Table Of Content. Outputs... 9
Table Of Content A european pilot network of reference centres in refractory epilepsy and epilepsy surgery... 2 Summary... 3 Coordinator, Leader contact and partners... 6 UNIVERSITAIR MEDISCH CENTRUM UTRECHT...
Menarini Foundation Symposia: 185
Menarini Foundation Symposia: 185 Focus on Rare Diseases Myeloproliferative and Myelodysplastic Syndromes, September 20 th - 22 nd, 2007 Organized by OSPEDALI RIUNITI BERGAMO ISTITUTO MARIO NEGRI FONDAZIONE
options in Myeloablative HSCT
Should Busilvex we use AlloSCT in AML options in Myeloablative HSCT Reduced Intensity or Myeloablative preparative protocols? Moderator: Andrea Bacigalupo Reduced Intensity: Arnon Nagler Myeloablative:
Operation of the European NGO Network for Smoking Prevention... 2 Summary... 3 Coordinator, Leader contact and partners... 5
Table Of Content Operation of the European NGO Network for Smoking Prevention... 2 Summary... 3 Coordinator, Leader contact and partners... 5 A.N.P.AS. Associazione Nazionale Pubbliche Assistenze... 5
Statistical Table 13: Prevalence of HIV infection (%) among injecting drug users under age 25, in the EU (sample sizes between brackets)
Statistical Table 3: Prevalence of HIV infection (%) among injecting drug users under, in the EU (sample sizes between brackets) HIV IDUs under Belgium, French Community 99 992 993 994 995 996 997 998
MARCH 2012 CALL FELLOWSHIP PROGRAMME WINNERS
MARCH 2012 CALL FELLOWSHIP PROGRAMME WINNERS Short-term Fellowships Dr. Dominika Maciorkowska Departent of Invasive Cardiology, University Hospital in Bialystok BIALYSTOK - POLAND Dept. of Nephrology,
Funding research for the future
Funding research for the future Dr Helen Compton (helen.compton@nihr.ac.uk) Stakeholder Engagement Manager NIHR, Central Commissioning Facility The future of health and social care depends on today's research
Department of Biological Standardisation OMCL Network & Healthcare (DBO)
Department of Biological Standardisation OMCL Network & Healthcare (DBO) Implementation of Pathogen Reduction Technologies for Blood Components for Transfusion: Updated Table 2009-2010 COUNCIL OF EUROPE
Phase II Study of Subcutaneous Injection Depot of Octreotide in Patients With Acromegaly and Ne uroe ndocrine Tumours (NETs)
A service of the U.S. National Institutes of Health Trial record 1 of 4 for: CAMURUS Previous Study Return to List Next Study Phase II Study of Subcutaneous Injection Depot of Octreotide in Patients With
Statistical Table 17: Prevalence of hepatitis C infection among injecting drug users under age 25 in the EU (%) (sample sizes between brackets)
Belgium, French Community 99 992 993 994 995 996 997 998 999 2000 200 / 40.9 (22) 47.4 (38) 3.9 (38) 26.7 (5) SR centres; self-reported test results. > 80% missing data. Belgium, French Community - Charleroi
SUPPLEMENTARY APPENDIX
SUPPLEMENTARY APPENDIX The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network Niels W.C.J.
Table Of Content. Monitoring Suicidal Behaviour in Europe... 2 Summary... 3 Coordinator, Leader contact and partners Outputs...
Table Of Content Monitoring Suicidal Behaviour in Europe... 2 Summary... 3 Coordinator, Leader contact and partners... 5 University Psychiatric Hospital, Centre for Mental Health... 5 Psychiatry Ambulatory
Quality and Safety of HSCT in Autoimmune Diseases
Quality and Safety of HSCT in Autoimmune Diseases Dr John Snowden Stem Cell Transplant Programme Director Sheffield Teaching Hospitals and University of Sheffield & JACIE Medical Director 1 HSCT is GROWING
Table Of Content. Outputs... 9
Table Of Content European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Klinikum Dortmund ggmbh... 5 Uniwersytet
Statistical Table 20: Prevalence of antibodies against hepatitis B virus among injecting drug users in the EU (sample sizes in brackets)
Belgium, French Community 23.5 (5 23.8 (240 20.0 (95 5.7 (27 SR selfreported test results; > 80% missing data. Belgium, Flemish Community 7.9 (06 20.0 (55 2.7 (57 5.0 (33 7. (3 AHBs. Drug, 2 Belgium, Flemish
Esme Moniz Cook University of Hull Centre of Dementia Research and Practice Humber NHS FT 16 September 2014
Esme Moniz Cook University of Hull Centre of Dementia Research and Practice Humber NHS FT 16 September 2014 What is psychosocial intervention applied research INTERDEM: Psychosocial INTERvention DEMentia
Smokefree Policies in Europe: Are we there yet?
Smokefree Policies in Europe: Are we there yet? 14 April 2015, 9:00 10:30am Rue de l Industrie 24, 1040 Brussels Permanent Partners: Temporary Partners: The research for the SFP Smokefree Map was partially
ACST-2... world* but we as a. lots more patients! is nearly the biggest investigator-led trial in the. collaborative group. must keep recruiting
ACST-2... is nearly the biggest investigator-led trial in the world* but we as a collaborative group must keep recruiting lots more patients! So far in 2013 a total of 72 patients have been recruited into
Organization of the clinical activity of Geriatric Oncology: Report of a SIOG (International Society of Geriatric Oncology) task force
Critical Reviews in Oncology/Hematology 62 (2007) 62 73 Organization of the clinical activity of Geriatric Oncology: Report of a SIOG (International Society of Geriatric Oncology) task force Silvio Monfardini
Management of Hematological Cancer in Older People
Management of Hematological Cancer in Older People Ulrich Wedding Riccardo A. Audisio Editors Management of Hematological Cancer in Older People Editors Ulrich Wedding Department of Palliative Care University
French Networks for Sarcoma and GIST. O Mir, JY Blay
French Networks for Sarcoma and GIST O Mir, JY Blay Introduction Since 2009 a network of 26 reference multidisciplinary centers aiming to improve the quality of care for sarcoma patients in France was
Supplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: San Miguel JF, Schlag R, Khuageva NK, et al. Bortezomib plus
Virtual Tumorboards del diagnóstico al tratamiento. Christian Fegeler CENS TechTalks, Santiago de Chile,
Virtual Tumorboards del diagnóstico al tratamiento Christian Fegeler CENS TechTalks, Santiago de Chile, 08.03.2018 ... our molecular tumor board (MTB) started in May 2017 weekly conference Multidisciplinary
Practical experience in implementing surveillance of antiviral resistance in several European countries in accordance with personal data regulation
Practical experience in implementing surveillance of antiviral resistance in several European countries in accordance with personal data regulation Katja Deterding Medizinische Hochschule Hannover Antiviral
Update on the ERIC TP53 Network Activities and TP53 Certification Overview and Results of Round 4
Update on the ERIC TP53 Network Activities and TP53 Certification Overview and Results of Round 4 Sarka Pospisilova Jitka Malcikova CEITEC, Masaryk University and University Hospital Brno, Czech Republic
Palliative nursing care of children and young people across Europe
Palliative nursing care of children and young people across Europe Results of a postal survey in August 2016 Updated in April 2017 (presented at the 29th PNAE-meeting in Naples/Italy on 28th April 2017)
Supplementary Online Content
Supplementary Online Content D Angelo SP, Russell J, Lebbé C, et al. Efficacy and safety of first-line avelumab treatment in patients with stage IV metastatic Merkel cell carcinoma: a preplanned interim
EBAMP European Board for Accreditation in Medical Physics
EBAMP European Board for Accreditation in Medical Physics www.ebamp.eu ACCREDITED EVENTS up to June 30th, 2018 App ID Institution Name Event Type Event Title Event Date Event Venue EBAMP CPD points APP-00073
24 October 2017 Paris, France
INTERNATIONAL COURSE PRELIMINARY PROGRAMME MS Academia: Multiple sclerosis advanced course 24 October 2017 Paris, France MS Academia - Multiple sclerosis advanced course Overview The complex world of multiple
Urgent need for integrated oncology and palliative care
Media contact ESMO Press Office E-mail media@esmo.org Tel: +41 (0)91 973 19 07 PRESS RELEASE EMBARGOED until Monday, 24 September 2012, 00:01 hours (CEST) Urgent need for integrated oncology and palliative
Preliminary programme ESLCCC September 2016
Preliminary programme ESLCCC 2016 22-23 September 2016 1 st day - Thursday 22 September 2016 8.45 17.00 Registration starts at 7.30 in the morning Welcome and Introduction By the ESLCCC 16 Committee Female
Making connections. Bilateral Cochlear Implant Audit
Making connections. Bilateral Cochlear Implant Audit Results from the National Paediatric Bilateral Cochlear Implant Audit Who was involved? The project included 1001 children, aged from a few months to
2019 GISM Annual Meeting
Save the date 2019 GISM Annual Meeting GENOVA 4-5 April Centro Congressi IST Nord - Ospedale Policlinico San Martino RESEARCH CHALLENGES FOR CLINICAL APPLICATION OF MSCs DI.M.I. Dipartimento di Medicina
EIA EU Ivory Seizures: January December 2017
() weight, 3.35/tusk to United Kingdom ivory seizures for year 2000 2000 Tusks, pieces unknown 214.4 FALSE Gatwick Airport ivory seizure, 25 January 2000 2000 Pieces 72 78 FALSE Portugal Portugal ivory
WCPT COUNTRY PROFILE December 2017 SWEDEN
WCPT COUNTRY PROFILE December 2017 SWEDEN SWEDEN NUMBERS WCPT Members Practising physical therapists 11,043 Total number of physical therapist members in your member organisation 17,906 Total number of
Franchi Massimo Piergiuseppe. Policlinico Universitario G Rossi, Azienda Ospedaliera Universitaria Integrata di Verona Verona 2012
Curriculum Vitae Personal information First name(s) / Surname(s) Franchi Massimo Piergiuseppe Telephone(s) 0039 045 8122720 Fax(es) 0039 045 8123394 E-mail(s) Nationality massimo.franchi@univr.it Italian
End of life care in children with cancer: a national survey from the Italian Association of Pediatric Hematology and Oncology (AIEOP)
End of life care in children with cancer: a national survey from the Italian Association of Pediatric Hematology and Oncology (AIEOP) 1 F. Benini, 3 A. Ferrante, 1 C. Pò, 1 R. Scarani, 4 A. Malvezzi, 2
INTERNATIONAL PROSPECTIVE STUDY ON DISTAL INTESTINAL OBSTRUCTION SYNDROME (DIOS). ASSOCIATED FACTORS and OUTCOMES..
INTERNATIONAL PROSPECTIVE STUDY ON DISTAL INTESTINAL OBSTRUCTION SYNDROME (DIOS). ASSOCIATED FACTORS and OUTCOMES.. Anne Munck1, Corinne Alberti 1, Priscilla Boizeau 1, Carla Colombo2 Natalia Kashirskaya
Table Of Content. European Surveillance of Congenital Anomalies (Phase 3)... 3 Summary... 4 Coordinator, Leader contact and partners...
Table Of Content European Surveillance of Congenital Anomalies (Phase 3)... 3 Summary... 4 Coordinator, Leader contact and partners... 5 Registry of Congenital Anomalies... 5 CNR Institute of Clinical
WCPT COUNTRY PROFILE December 2017 HUNGARY
WCPT COUNTRY PROFILE December 2017 HUNGARY HUNGARY NUMBERS WCPT Members Practising physical therapists 727 Total number of physical therapist members in your member organisation 4,000 Total number of practising
Clinical Oncology UK Workforce Report 2012 Faculty of Clinical Oncology
www.rcr.ac.uk Clinical Oncology UK Workforce Report 2012 Faculty of Clinical Oncology www.rcr.ac.uk Contents Foreword 3 1. Introduction and objectives 4 2. Census methodology 5 3. UK clinical oncology
WCPT COUNTRY PROFILE December 2017 SERBIA
WCPT COUNTRY PROFILE December 2017 SERBIA SERBIA NUMBERS WCPT Members Practising physical therapists 622 Total number of physical therapist members in your member organisation 3,323 Total number of practising
4nd Patient and Family Day
4nd Patient and Family Day EBMT Slide template Barcelona 7 February 2008 EBMT 2010 Vienna, Austria ; www.ebmt.org History of Stem Cell Transplantation Appelbaum et al, NEJM 2006 What is EBMT? Scientific,
European Child & Adolescent Psychopharmacology Network (ECAPN)
European Child & Adolescent Psychopharmacology Network (ECAPN) Established by members of the European Child & Adolescent Network of the European College of Neuropsychopharmacology (ECNP; https://www.ecnp.eu/
Further Section. Horm Res 1997;48:48-50
Further Section Horm Res 1997;48:48-50 Congress Calendar 21.06.-24.06.1997 Boston, Mass. 22.06.-25.06.1997 Edinburgh Scotland 22.06.-26.06.1997 Stockholm Sweden 29.06.-02.07.1997 Philadelphia 04.07.-05.07.1997
ESPNIC Endorsed Advanced Simulation Course. Program
ESPNIC Endorsed Advanced Simulation Course Technological Training Center, La Coruña (Spain), 25 th & 26 th April 2019 Thursday, 25 April 2019 Program Time Activity Instructor/Speaker 8.30-8.45 Presentation,
A continuous Educational Programme from Basic Immunology to Clinical Neuroimmunology PROFILE 2017
A continuous Educational Programme from Basic Immunology to Clinical Neuroimmunology PROFILE 2017 ABOUT US Gianvito Martino (for the Scientific Committee) It is a pleasure to introduce this new, exciting
Table Of Content. European surveillance of travel associated legionnaires' disease... 2 Summary... 3 Coordinator, Leader contact and partners...
Table Of Content European surveillance of travel associated legionnaires' disease... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Statens Serum Institute... 5 National Environmental Health
Phase 2 placebo-controlled withdrawal study of the ASBT inhibitor maralixibat in children with Alagille syndrome 48-week efficacy analysis
Phase 2 placebo-controlled withdrawal study of the ASBT inhibitor maralixibat in children with Alagille syndrome 48-week efficacy analysis ICONIC Study Emmanuel Gonzales, Ekkehard Sturm, Michael Stormon,
Supplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Faivre-Finn C, Snee M, Ashcroft L, et al, for
European Summer School
European Summer School Ønsker om deltagelse i nedenstående summerschool bedes fremsendt til undertegnede senest d.1/4 2008. Ansøgning på max 1 side, samt CV på max 1 side. Bestyrelsen vil herefter indstille
SIOP Europe the European Society for Paediatric Oncology European Network for Cancer Research in Children and Adolescents
the European Society for Paediatric Oncology encca European Network for Cancer Research in Children and Adolescents EUROPEAN TRAINING PROGRAMME IN PAEDIATRIC HAEMATOLOGY AND ONCOLOGY EUROPEAN BOARD OF
Date Title Type Credits Locality Code. Clinical 2. 3-Jan-17 Advanced Nephrology Course Clinical 29 Oxford
Date Title Type Credits Locality Code 3-Jan-17 How to perform a range of otological procedures - two centuries of experience Clinical 2 1 Wimpole Street, London, W1G 0AE. 108668 3-Jan-17 Advanced Nephrology
Childhood Acute Lymphoblastic Leukemia
Childhood Acute Lymphoblastic Leukemia Ajay Vora Editor Childhood Acute Lymphoblastic Leukemia Editor Ajay Vora Department of Paediatric Haemotology Sheffield Children's Hospital NHS Trust University of
Table Of Content. Outputs... 7
Table Of Content Using Multidimensional Prognostic Indices(MPI)to improve costeffectiveness of interventions in multimorbid frail older persons.... 2 Summary... 3 Coordinator, Leader contact and partners...
Table Of Content. The European Influenza Surveillance Scheme... 2 Summary... 3 Coordinator, Leader contact and partners Outputs...
Table Of Content The European Influenza Surveillance Scheme... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Institut Pasteur... 6 Health Division... 6 Nphs Communicable Disease Surveillance
Undiagnosed Rare Diseases: a bilateral project between. Italy (Istituto Superiore di Sanità) and USA (NIH)
Undiagnosed Rare Diseases: a bilateral project between Italy (Istituto Superiore di Sanità) and USA (NIH) Domenica Taruscio & Marco Salvatore National Centre for Rare Diseases Istituto Superiore di Sanità,
2018 Congenital Hyperinsulinism Family Conference Athens, Greece The Wyndham Grand Athens Hotel September 25-26, 2018
2018 Congenital Hyperinsulinism Family Conference Athens, Greece The Wyndham Grand Athens Hotel September 25-26, 2018 Sponsored by: The Medical School of the National Kapodistrian University of Athens
EIP AHA Valencia 2016 Towards an Active and Healthy Ageing. Emilia-Romagna Region - Reference Site EIP-AHA
EIP AHA Valencia 2016 Towards an Active and Healthy Ageing Emilia-Romagna Region - Reference Site EIP-AHA A Regional Model to Predict Identify and Manage Multimorbidity and Frailty Mirca Barbolini Valencia
Published Ahead of Print on June 8, 2017, as doi: /haematol Copyright 2017 Ferrata Storti Foundation.
Published Ahead of Print on June 8, 2017, as doi:10.3324/haematol.2016.156901. Copyright 2017 Ferrata Storti Foundation. Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic
i-abc - Inhaled antibiotics in bronchiectasis and cystic fibrosis
PROYECTOS EUROPEOS EN LOS QUE PARTICIPA EL IRYCIS Innovative Medicines Initative i-abc - Inhaled antibiotics in bronchiectasis and cystic fibrosis http://www.imi.europa.eu/content/iabc Start Date: 01/08/2015
Maurille Feudjo Tepie Director, Observational Research, Amgen Ltd
The use of Historical Control Data to Assess the Benefits of New Therapies: A Case Study of Blinatumomab versus Standard Therapy of Adults relapsed/refractory Acute Lymphoblastic Leukaemia Maurille Feudjo
vs Microfracture Clear Indications Clinical Superiority Results from LEVEL OF EVIDENCE 1 Multicenter Randomized Controlled Trial proving Gothenburg
vs Microfracture Clear Indications proving Clinical Superiority Gothenburg Oslo Ghent Katowice Zürich Vienna Freiburg Bologna Verona Cape Town Results from LEVEL OF EVIDENCE 1 Multicenter Randomized Controlled
Surveillance of Tuberculosis in Europe - EuroTB
Surveillance of Tuberculosis in Europe - EuroTB Report on tuberculosis cases notified in 2000 Institut de Veille Sanitaire WHO Collaborating Centre for the Surveillance of Tuberculosis in Europe Royal
SCI Annual Report (2017) Editorial Office
SCI Annual Report (2017) Editorial Office editor@sci-online.org Outline of the Report 1. Basic Information 2. Editors of SCI 3. Distribution of Editorial Board Members 4. Number of Published Articles (results
Summary Attachment for EudraCT
Avenue E. Mounier 83/11 1200 Brussels Belgium Tel: +32 2 774 1611 Email: eortc@eortc.be www.eortc.org Summary Attachment for EudraCT Active Title of the Study 40013-22012 Investigators & Study Centers